Multi-modal Imaging of Myofascial Pain - Phase 2

Wednesday, January 7, 2026 12:00 AM

Conditions: Myofascial Pain Interventions: Drug: 50/50 Mixture of Lidocaine 1% injection + Bupivacaine 0.25% Injectable Solution; Procedure: Dry Needling Sponsors: Washington University School of Medicine; National Center for Complementary ...

Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients

Friday, January 2, 2026 12:00 AM

Conditions: Acute Lymphoblastic Leukemia Interventions: Device: ChromoSeq® assay testing Sponsors: Washington University School of Medicine; McDonnell Center Not yet recruiting

Improving Consent Experiences in Clinical Trials

Friday, December 26, 2025 12:00 AM

Conditions: Cancer Interventions: Behavioral: Standard Consent Form; Behavioral: Visual Key Information (VKI) page Sponsors: Washington University School of Medicine Withdrawn

Cancer Care Companion

Wednesday, January 7, 2026 12:00 AM

Conditions: Pediatric Cancer Interventions: Other: Cancer Care Companion Sponsors: Washington University School of Medicine; National Cancer Institute (NCI) Not yet recruiting

Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma

Monday, January 5, 2026 12:00 AM

Conditions: Pancreatic Adenocarcinoma; Cancer of the Pancreas; Pancreas Cancer; Pancreatic Cancer Interventions: Radiation: Stereotactic body radiotherapy; Drug: Defactinib; Drug: Avutometinib Sponsors: Washington University School of ...

Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction

Wednesday, December 31, 2025 12:00 AM

Conditions: ACL Injury; ACL Tears; ACL Surgery Interventions: Drug: Tranexamic Acid (TXA); Drug: Placebo Sponsors: Campbell Clinic; Duke University; University of Pittsburgh; Endeavor Health; University of Cincinnati; Washington University ...

TeamTalk: Improving Inter-professional Communication During Cancer Treatment

Wednesday, January 7, 2026 12:00 AM

Conditions: Pediatric Cancer Interventions: Behavioral: Multi-level communication intervention Sponsors: Washington University School of Medicine; St. Jude Children's Research Hospital; National Institutes of Health (NIH); National Cancer ...

A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Wednesday, December 31, 2025 12:00 AM

Conditions: Antibody Mediated Rejection of Lung Transplant Interventions: Drug: Siltuximab; Drug: Placebo Sponsors: Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI); University of Utah Recruiting